SYAB — Synlab AG Income Statement

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMid CapNeutral

Annual income statement for Synlab AG, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final
Revenue
Total Revenue	2,621	3,765	3,251	2,635
Cost of Revenue
Gross Profit	1,937	2,822	2,474	2,019
Selling / General / Administrative Expenses
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	2,306	2,850	3,019	2,576
Operating Profit	315	915	232	59.2
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	125	806	283	143
Provision for Income Taxes
Net Income After Taxes	37.9	610	153	93
Minority Interest
Net Income Before Extraordinary Items
Extraordinary Items
Net Income	258	625	151	92.3
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Dilution Adjustment
Diluted Net Income	258	607	151	92.3
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	0.72	2.9	1.21	0.64
Dividends per Share